Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTP4A1 pseudogene 3 (PTP4A1P3) is a genomic pseudogene related to the protein-coding gene PTP4A1, which encodes a protein tyrosine phosphatase implicated in cell signaling, proliferation, and cancer metastasis. Unlike its parent PTP4A1, PTP4A1P3 does not encode a functional protein, has no known biological activity, and is not considered a therapeutic target for drugs or disease intervention. In summary, PTP4A1P3 is a pseudogene and not a valid molecular target for therapeutic intervention. Entries referencing this as a therapeutic target, receptor, or enzyme are incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine phosphatase type IVA, member 1 pseudogene 3 (PTP4A1P3).